Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-047868

Director sold 5,721 shares at an average $16.81 ($96,148)

  • Director acquired 5,721 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CHESS ROBERT Director 2021-07-20 Option exercise +2,106 $13.80 $29,063 282,679 D: show line 1 in the form
CHESS ROBERT Director 2021-07-20 Sale −2,106 $16.80 $35,381 280,573 D: show line 2 in the form
CHESS ROBERT Director 2021-07-21 Option exercise +3,524 $13.80 $48,631 284,097 D: show line 3 in the form
CHESS ROBERT Director 2021-07-21 Sale −3,524 $16.81 $59,238 280,573 D: show line 4 in the form
CHESS ROBERT Director 2021-07-22 Option exercise +91 $13.80 $1,256 280,664 D: show line 5 in the form
CHESS ROBERT Director 2021-07-22 Sale −91 $16.80 $1,529 280,573 D: show line 6 in the form
Open-market sales · 5,721 sh · avg $16.81 · $96,148

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CHESS ROBERT Director 2021-07-20 Option exercise · Stock Option −2,106 21,894 D: show line 7 in the form
CHESS ROBERT Director 2021-07-21 Option exercise · Stock Option −3,524 18,370 D: show line 8 in the form
CHESS ROBERT Director 2021-07-22 Option exercise · Stock Option −91 18,279 D: show line 9 in the form
Loading xslF345X03/doc4.xml…